About this trial
This is a prospective randomized study to compare endoscopic combined intrarenal surgery and PCNL as modalities of treatment for staghorn stones. In terms of efficacy and safety
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients are more than 18 and less than 65 years old.
Patients with renal staghorn stones based on imaging modalities (stones occupying the renal pelvis and extending into at least 2 major calyces).
Disqualifiers
Patients with renal insufficiency (serum creatinine > 1.6 mg/dl)
patients with active urinary tract infection.
Patients with congenital renal anomalies.
Morbid obesity (BMI > 35 kg/m2).
Trial design
Parallel
Treatments tested in this trial
Combined Intrarenal Surgery and percutaneous nephrolithotomy
Procedure/SurgeryA study was conducted to compare endoscopic combined intrarenal surgery and percutaneous nephrolithotomy as modalities of treatment for staghorn stones.
Treatment groups
Trial outcomes
Primary outcomes
stone-free rate
Stone-free is defined as no residual stones on CT-UT or clinically insignificant residual fragments (CIRF) less than 4 mm in diameter. It will be measured twice, first immediately postoperatively, and then again after 3 months of the procedure.
Secondary outcomes
Safety of the procedure
Intra and post-operative complications
Sponsors and contacts
Click on the lead sponsor to view all of their trials.